Patient Characteristics and Medication Utilization Patterns of Infliximab-Treated Rheumatoid Arthritis Patients Subsequently Transitioned to Intravenous Golimumab

被引：0
|
作者：
Ellis, Lorie A. [1 ]
DeHoratius, Raphael J. [2 ,3 ]
Kafka, Shelly [2 ]
Varker, Helen [4 ]
Brouillette, Matthew [4 ]
Malangone-Monaco, Elisabetta [4 ]
机构：
[1] Janssen Sci Affairs LLC, Hlth Econ & Outcomes Res, Horsham, PA USA
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Thomas Jefferson Univ, Sidney Kimmel Sch Med, Philadelphia, PA USA
[4] Truven Hlth Analyt, Bethesda, MD USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2493
引用
收藏
页数：3
相关论文
共 50 条
  • [31] United States Rheumatology Practice-Based Real-World Evidence of Methotrexate Utilization and esponse to Therapy in Rheumatoid Arthritis Patients Treated with Intravenous Golimumab
    Broadwell, Aaron
    Bray, Vance
    Conaway, Douglas
    Schechtman, Joy
    Kivitz, Alan J.
    Parenti, Dennis
    Black, Shawn
    Xu, Stephen
    Langholff, Wayne
    Kafka, Shelly
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in rheumatoid arthritis patients treated with multiple intravenous infusions of infliximab
    Klimíuk, P
    Sierakowski, S
    Domyslawska, I
    Chwiecko, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 251 - 251
  • [33] Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in rheumatoid arthritis patients treated with multiple intravenous infusions of infliximab
    Klimiuk, PA
    Sierakowski, S
    Domyslawska, I
    Chwiecko, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 249 - 249
  • [34] Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
    Marotte, Hubert
    Mammar, Nadir
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Intravenous Antiseizure Medication Utilization Patterns Among Seizure Patients Treated in US Hospitals: a Database Analysis
    Beaty, Silky
    Rosenthal, Ning
    Gayle, Julie
    Dongre, Prashant
    Ricchetti-Masterson, Kristen
    NEUROLOGY, 2021, 96 (15)
  • [36] Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
    Bingham, Clifton O.
    Black, Shawn
    Shiff, Natalie J.
    Xu, Stephen
    Langholff, Wayne
    Curtis, Jeffrey R.
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 659 - 678
  • [37] Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
    Clifton O. Bingham
    Shawn Black
    Natalie J. Shiff
    Stephen Xu
    Wayne Langholff
    Jeffrey R. Curtis
    Rheumatology and Therapy, 2023, 10 : 659 - 678
  • [38] REAL-WORLD, MULTI-SITE, OBSERVATIONAL STUDY OF INFUSION TIME AND TREATMENT SATISFACTION IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB (GLM-IV) OR INFLIXIMAB (IFX)
    Ellis, L.
    Le, C.
    McDermott, J. D., Jr.
    Daniel, S.
    VALUE IN HEALTH, 2017, 20 (05) : A149 - A149
  • [39] Application of a new immunohistology scoring system (IH score): Analysis of TNF-α in synovium related to disease activity score in infliximab-treated patients with rheumatoid arthritis
    Kanbe, Katsuaki
    Hara, Ryota
    Chiba, Junji
    Inoue, Yasuo
    Taguchi, Masashi
    Tanaka, Yasuhito
    MODERN RHEUMATOLOGY, 2014, 24 (06) : 910 - 914
  • [40] Patterns of Abatacept Utilization in Patients with Rheumatoid Arthritis. Have the Baseline Characteristics of These Patients Changed over Time?
    Victoria Hernandez, M.
    Sanchez-Piedra, Carlos
    Inciarte-Mundo, Jose
    Sanchez-Alonso, Fernando
    Manero, Javier
    Rosello, Rosa
    Perez-Pampin, Eva
    Morla, Rosa
    Rodriguez-Lozano, Carlos
    Ruiz-Montesinos, Dolores
    Sanmarti, Raimon
    Gomez-Reino, Juan J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345